Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Glycoprotéines membranaires (immunologie) - Protéines de l'enveloppe virale (immunologie)

Terms

224Glycoprotéines membranaires (immunologie)
244Protéines de l'enveloppe virale (immunologie)
289Glycoprotéines membranaires (génétique)
340Protéines de l'enveloppe virale (génétique)
567Glycoprotéine de spicule des coronavirus
215Glycoprotéines membranaires (métabolisme)
265Protéines de l'enveloppe virale (métabolisme)
153Tests de neutralisation

Associations

Freq.WeightAssociation
2210.945Glycoprotéines membranaires (immunologie) - Protéines de l'enveloppe virale (immunologie)
2850.909Glycoprotéines membranaires (génétique) - Protéines de l'enveloppe virale (génétique)
2870.709Glycoprotéine de spicule des coronavirus - Glycoprotéines membranaires (génétique)
2960.674Glycoprotéine de spicule des coronavirus - Protéines de l'enveloppe virale (génétique)
2200.617Glycoprotéine de spicule des coronavirus - Glycoprotéines membranaires (immunologie)
2110.604Glycoprotéine de spicule des coronavirus - Glycoprotéines membranaires (métabolisme)
2100.880Glycoprotéines membranaires (métabolisme) - Protéines de l'enveloppe virale (métabolisme)
2240.602Glycoprotéine de spicule des coronavirus - Protéines de l'enveloppe virale (immunologie)
2150.555Glycoprotéine de spicule des coronavirus - Protéines de l'enveloppe virale (métabolisme)
1130.444Glycoprotéines membranaires (génétique) - Glycoprotéines membranaires (immunologie)
1300.433Protéines de l'enveloppe virale (génétique) - Protéines de l'enveloppe virale (métabolisme)
1220.424Protéines de l'enveloppe virale (génétique) - Protéines de l'enveloppe virale (immunologie)
1120.422Glycoprotéines membranaires (génétique) - Protéines de l'enveloppe virale (immunologie)
1010.405Glycoprotéines membranaires (génétique) - Glycoprotéines membranaires (métabolisme)
1110.402Glycoprotéines membranaires (immunologie) - Protéines de l'enveloppe virale (génétique)
750.388Protéines de l'enveloppe virale (immunologie) - Tests de neutralisation
710.384Glycoprotéines membranaires (immunologie) - Tests de neutralisation
1010.374Glycoprotéines membranaires (métabolisme) - Protéines de l'enveloppe virale (génétique)
990.358Glycoprotéines membranaires (génétique) - Protéines de l'enveloppe virale (métabolisme)
830.282Glycoprotéine de spicule des coronavirus - Tests de neutralisation
500.238Glycoprotéines membranaires (génétique) - Tests de neutralisation
530.232Protéines de l'enveloppe virale (génétique) - Tests de neutralisation
470.185Protéines de l'enveloppe virale (immunologie) - Protéines de l'enveloppe virale (métabolisme)

Documents par ordre de pertinence
002A25 (2009) Kexia Yan [République populaire de Chine] ; Wenjie Tan ; Huijuan Wang ; Yue Wang ; Xiangmin Zhang ; Yan Li ; Li RuanSARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
003694 (2007) Benoît Callendret [France] ; Valérie Lorin [France] ; Pierre Charneau [France] ; Philippe Marianneau [France] ; Hugues Contamin [France] ; Jean-Michel Betton [France] ; Sylvie Van Der Werf [France] ; Nicolas Escriou [France]Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS
003988 (2007) Lei Ba [États-Unis] ; Christopher E. Yi [États-Unis] ; Linqi Zhang [États-Unis] ; David D. Ho [États-Unis] ; Zhiwei Chen [États-Unis]Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus
003F36 (2006) Yuxian He [États-Unis] ; Jingjing Li ; Wenhui Li ; Sara Lustigman ; Michael Farzan ; Shibo JiangCross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.
004285 (2006) Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Masayuki Saijo [Japon] ; Ichiro Kurane [Japon] ; Fumihiro Taguchi [Japon] ; Masato Tashiro [Japon] ; Shigeru Morikawa [Japon]Evaluation of a novel vesicular stomatitis virus pseudotype‐based assay for detection of neutralizing antibody responses to SARS‐CoV
004684 (2005) Yuxian He [États-Unis] ; Hong Lu ; Pamela Siddiqui ; Yusen Zhou ; Shibo JiangReceptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
004939 (2005) Ran-Yi Liu [République populaire de Chine] ; Li-Zhi Wu ; Bi-Jun Huang ; Jia-Ling Huang ; Yan-Ling Zhang ; Miao-La Ke ; Jun-Mei Wang ; Wei-Ping Tan ; Ru-Hua Zhang ; Han-Kui Chen ; Yi-Xin Zeng ; Wenlin HuangAdenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.
004F28 (2004) Yun Zhang [République populaire de Chine] ; Fan Yang ; Yan-Han Li ; Wen-Hui Li ; Xin-Ming Tu ; Qiang Wei ; Hua Zhu ; Li Liu ; Heng Wang ; Chuan Qin ; Guo-Yong Yuan ; Wei He ; Shu-Hui Wang[Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
005A72 (2004) Heike Hofmann [Allemagne] ; Kim Hattermann [Allemagne] ; Andrea Marzi [Allemagne] ; Thomas Gramberg [Allemagne] ; Martina Geier [Allemagne] ; Mandy Krumbiegel [Allemagne] ; Seraphin Kuate [Allemagne] ; Klaus Überla [Allemagne] ; Matthias Niedrig [Allemagne] ; Stefan Pöhlmann [Allemagne]S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients
005A75 (2004) Tsanan Giroglou [Allemagne] ; Jindrich Jr Cinatl [Allemagne] ; Holger Rabenau [Allemagne] ; Christian Drosten [Allemagne] ; Harald Schwalbe [Allemagne] ; Hans Wilhelm Doerr [Allemagne] ; Dorothee Von Laer [Allemagne]Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein
006473 (2000) Fumihiro Taguchi ; Yohko K. ShimazakiFunctional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity.
001D61 (2012) Kuan-Hsun Lin [Taïwan] ; Chuen-Fu Lin ; Shyan-Song Chiou ; Ai-Ping Hsu ; Min-Shiuh Lee ; Chao-Chin Chang ; Tien-Jye Chang ; Jui-Hung Shien ; Wei-Li HsuApplication of purified recombinant antigenic spike fragments to the diagnosis of avian infectious bronchitis virus infection.
002385 (2011) Ye V. Liu [États-Unis] ; Michael J. Massare [États-Unis] ; Dale L. Barnard [États-Unis] ; Thomas Kort [États-Unis] ; Margret Nathan [États-Unis] ; LEI WANG [États-Unis] ; Gale Smith [États-Unis]Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
002B00 (2009) Yanbo Lv ; Zhihua Ruan ; Li Wang ; Bing Ni ; Yuzhang WuIdentification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV
003013 (2008) Che-Man Chan [Hong Kong] ; Patrick C Y. Woo ; Susanna K P. Lau ; Herman Tse ; Hong-Lin Chen ; Feng Li ; Bo-Jian Zheng ; Ling Chen ; Jian-Dong Huang ; Kwok-Yung YuenSpike protein, S, of human coronavirus HKU1: role in viral life cycle and application in antibody detection.
003558 (2007) Wei Wang ; Linbai Ye ; Li Ye ; Baozong Li ; Bo Gao ; Yingchun Zeng ; Lingbao Kong ; Xiaonan Fang ; Hong Zheng ; Zhenghui Wu ; Yinglong SheUp-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathway
004004 (2006) Yuxian He ; Jingjing Li ; Shibo JiangA single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity
004612 (2005) Fang Li [États-Unis] ; Wenhui Li ; Michael Farzan ; Stephen C. HarrisonStructure of SARS coronavirus spike receptor-binding domain complexed with receptor.
004739 (2005) Qigai He ; Ivanus Manopo ; Liqun Lu ; Bernard P. Leung ; Hiok Hee Chng ; Ai Ee Ling ; Li Lian Chee ; Shzu-Wei Chan ; Eng Eong Ooi ; Yeo Lee Sin ; Brenda Ang ; Jimmy KwangNovel Immunofluorescence Assay Using Recombinant Nucleocapsid-Spike Fusion Protein as Antigen To Detect Antibodies against Severe Acute Respiratory Syndrome Coronavirus
005007 (2004) Xiao Dong Wu [République populaire de Chine] ; Bo Shang ; Rui Fu Yang ; Hao Yu ; Zhi Hai Ma ; Xu Shen ; Yong Yong Ji ; Ying Lin ; Ya Di Wu ; Guo Mei Lin ; Lin Tian ; Xiao Qing Gan ; Sheng Yang ; Wei Hong Jiang ; Er Hei Dai ; Xiao Yi Wang ; Hua Liang Jiang ; You Hua Xie ; Xue Liang Zhu ; Gang Pei ; Lin Li ; Jia Rui Wu ; Bing SunThe spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells.
005041 (2004) Hyun Chul Song ; Mi-Young Seo ; Konrad Stadler ; Byoung J. Yoo ; Qui-Lim Choo ; Stephen R. Coates ; Yasushi Uematsu ; Takashi Harada ; Catherine E. Greer ; John M. Polo ; Piero Pileri ; Markus Eickmann ; Rino Rappuoli ; Sergio Abrignani ; Michael Houghton ; Jang H. HanSynthesis and Characterization of a Native, Oligomeric Form of Recombinant Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein
005457 (2004) Tin-Yun Ho [Taïwan] ; Shih-Lu Wu ; Shin-Ei Cheng ; Yen-Chiao Wei ; Shan-Ping Huang ; Chien-Yun HsiangAntigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.
005586 (2004) Yong Xiu Yao [Royaume-Uni] ; Junyuan Ren [Royaume-Uni] ; Paul Heinen [Royaume-Uni] ; Maria Zambon [Royaume-Uni] ; Ian M. Jones [Royaume-Uni]Cleavage and Serum Reactivity of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
006107 (2003) Yan Ren ; Zhengfeng Zhou ; Jinxiu Liu ; Liang Lin ; Shuting Li ; Hao Wang ; Ji Xia ; Zhe Zhao ; Jie Wen ; Cuiqi Zhou ; Jingqiang Wang ; Jianning Yin ; Ningzhi Xu ; Siqi LiuA Strategy for Searching Antigenic Regions in the SARS-CoV Spike Protein
006547 (1995) J M Torres [Espagne] ; C. Sánchez ; C. Su É ; C. Smerdou ; L. Prevec ; F. Graham ; L. EnjuanesInduction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein.
001918 (2013) Jie Li [États-Unis] ; Laura Ulitzky ; Erica Silberstein ; Deborah R. Taylor ; Raphael ViscidiImmunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates.
001D12 (2012) Hatem A. Elshabrawy [États-Unis] ; Melissa M. Coughlin ; Susan C. Baker ; Bellur S. PrabhakarHuman monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing.
001D33 (2012) Kazuya Shirato ; Miyuki Kawase ; Oshi Watanabe [Japon] ; Chika Hirokawa [Japon] ; Shutoku Matsuyama ; Hidekazu Nishimura [Japon] ; Fumihiro Taguchi [Japon]Differences in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004-2008 depend on the S1 region sequence of the spike protein.
002140 (2011) Liu Di-Qiu ; Qiao Xin-Yuan ; Ge Jun-Wei ; Tang Li-Jie ; Jiang Yan-Ping ; Li Yi-JingConstruction and characterization of Lactobacillus pentosus expressing the D antigenic site of the spike protein of Transmissible gastroenteritis virus.
002522 (2010) Yu-Xuan Hou [République populaire de Chine] ; Cheng Peng ; Zheng-Gang Han ; Peng Zhou ; Ji-Guo Chen ; Zheng-Li ShiImmunogenicity of the spike glycoprotein of bat SARS-like coronavirus.
002653 (2010) Barry Rockx [États-Unis] ; Eric Donaldson ; Matthew Frieman ; Timothy Sheahan ; Davide Corti [Suisse] ; Antonio Lanzavecchia [Suisse] ; Ralph S. BaricEscape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus
002A40 (2009) Lanying Du [États-Unis] ; Guangyu Zhao [République populaire de Chine] ; Chris C. S. Chan [République populaire de Chine] ; Shihui Sun [République populaire de Chine] ; Min Chen [République populaire de Chine] ; Zhonghua Liu [États-Unis] ; Hongxiang Guo [États-Unis] ; Yuxian He [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Bo-Jian Zheng [République populaire de Chine] ; Shibo Jiang [États-Unis]Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
002A62 (2009) Lijie Tang [République populaire de Chine] ; Yijing LiOral immunization of mice with recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis virus spike glycoprotein.
003034 (2008) Sagar U. Kapadia [États-Unis] ; Ian D. Simon ; John K. RoseSARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector.
003147 (2008) Kumari G. Lokugamage [États-Unis] ; Naoko Yoshikawa-Iwata ; Naoto Ito ; Douglas M. Watts ; Philip R. Wyde ; Nan Wang ; Patrick Newman ; Chien-Te Kent Tseng ; C J Peters ; Shinji MakinoChimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV.
003484 (2008) Timothy Sheahan [États-Unis] ; Barry Rockx [États-Unis] ; Eric Donaldson [États-Unis] ; Davide Corti [Suisse] ; Ralph Baric [États-Unis]Pathways of Cross-Species Transmission of Synthetically Reconstructed Zoonotic Severe Acute Respiratory Syndrome Coronavirus
003519 (2008) Yu-Ya Mitsuki [Japon] ; Kazuo Ohnishi [Japon] ; Hirotaka Takagi [Japon] ; Masamichi Oshima [Japon] ; Takuya Yamamoto [Japon] ; Fuminori Mizukoshi [Japon] ; Kazutaka Terahara [Japon] ; Kazuo Kobayashi [Japon] ; Naoki Yamamoto [Japon] ; Shoji Yamaoka [Japon] ; Yasuko Tsunetsugu-Yokota [Japon]A single amino acid substitution in the Sl and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV
003523 (2008) Julie E. Martin [États-Unis] ; Mark K. Louder [États-Unis] ; Lasonji A. Holman [États-Unis] ; Ingelise J. Gordon [États-Unis] ; Mary E. Enama [États-Unis] ; Brenda D. Larkin [États-Unis] ; Charla A. Andrews [États-Unis] ; Leatrice Vogel [États-Unis] ; Richard A. Koup [États-Unis] ; Mario Roederer [États-Unis] ; Robert T. Bailer [États-Unis] ; Phillip L. Gomez [États-Unis] ; Martha Nason [États-Unis] ; John R. Mascola [États-Unis] ; Gary J. Nabel [États-Unis] ; Barney S. Graham [États-Unis]A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
003589 (2007) D B Sun [République populaire de Chine] ; L. Feng ; H Y Shi ; J F Chen ; S W Liu ; H Y Chen ; Y F WangSpike protein region (aa 636789) of porcine epidemic diarrhea virus is essential for induction of neutralizing antibodies.
003654 (2007) Li Liu ; Qing Fang ; Fei Deng ; Hanzhong Wang ; Christopher E. Yi ; Lei Ba ; Wenjie Yu ; Richard D. Lin ; Taisheng Li ; Zhihong Hu ; David D. Ho ; Linqi Zhang ; Zhiwei ChenNatural Mutations in the Receptor Binding Domain of Spike Glycoprotein Determine the Reactivity of Cross-Neutralization between Palm Civet Coronavirus and Severe Acute Respiratory Syndrome Coronavirus▿
003708 (2007) Seraphin Kuate [Allemagne] ; Jindrich Cinatl [Allemagne] ; Hans Wilhelm Doerr [Allemagne] ; Klaus Überla [Allemagne]Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies
003746 (2007) Yuan Zhang [République populaire de Chine] ; Nan Zheng ; Yang ZhongComputational characterization and design of SARS coronavirus receptor recognition and antibody neutralization.
003C76 (2006) Brian Tripet [États-Unis] ; Daniel J. Kao ; Scott A. Jeffers ; Kathryn V. Holmes ; Robert S. HodgesTemplate-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
003C93 (2006) William C. Hwang [États-Unis] ; Yaqiong Lin ; Eugenio Santelli ; Jianhua Sui ; Lukasz Jaroszewski ; Boguslaw Stec ; Michael Farzan ; Wayne A. Marasco ; Robert C. LiddingtonStructural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.
003D26 (2006) Masahiro Kitabatake [Japon] ; Shingo Inoue [Japon] ; Fumihiko Yasui [Japon] ; Shoji Yokochi [Japon] ; Masaaki Arai [Japon] ; Kouichi Morita [Japon] ; Hisatoshi Shida [Japon] ; Minoru Kidokoro [Japon] ; Fukashi Murai [Japon] ; Mai Quynh Le [Viêt Nam] ; Kyosuke Mizuno [Japon] ; Kouji Matsushima [Japon] ; Michinori Kohara [Japon]SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus
003E15 (2006) Kuo-Ming Lip ; Shuo Shen ; Xiaoming Yang ; Choong-Tat Keng ; Aihua Zhang ; Hsueh-Ling Janice Oh ; Zhi-Hong Li ; Le-Ann Hwang ; Chih-Fong Chou ; Burtram C. Fielding ; Timothy H P. Tan ; Josef Mayrhofer ; Falko G. Falkner ; Jianlin Fu ; Seng Gee Lim ; Wanjin Hong ; Yee-Joo TanMonoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.
003E24 (2006) Natalia Tarnovitski [Israël] ; Leslie J. Matthews ; Jianhua Sui ; Jonathan M. Gershoni ; Wayne A. MarascoMapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptides.
003E74 (2006) Jan Ter Meulen ; Edward N. Van Den Brink ; Leo L. M. Poon ; Wilfred E. Marissen ; Cynthia S. W. Leung ; Freek Cox ; Chung Y. Cheung ; Arjen Q. Bakker ; Johannes A. Bogaards ; Els Van Deventer ; Wolfgang Preiser ; Hans Wilhelm Doerr ; Vincent T. Chow ; John De Kruif ; Joseph S. M. Peiris ; Jaap GoudsmitHuman Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
004364 (2006) Mo Liu [République populaire de Chine] ; Chunfang Gu [République populaire de Chine] ; Jianguo Wu [République populaire de Chine] ; Ying Zhu [République populaire de Chine]Amino acids 1 to 422 of the spike protein of SARS associated coronavirus are required for induction of cyclooxygenase-2
004442 (2006) Yi-Ping Shih [Taïwan] ; Chia-Yen Chen [Taïwan] ; Shih-Jen Liu [Taïwan] ; Kuan-Hsuan Chen [Taïwan] ; Yuan-Ming Lee [Taïwan] ; Yu-Chan Chao [Taïwan] ; Yi-Ming Arthur Chen [Taïwan]Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus
004469 (2006) Raymond H. See [Canada] ; Alexander N. Zakhartchouk [Canada] ; Martin Petric [Canada] ; David J. Lawrence [Canada] ; Catherine P. Y. Mok [Canada] ; Robert J. Hogan [États-Unis] ; Thomas Rowe [États-Unis] ; Lois A. Zitzow [États-Unis] ; Karuna P. Karunakaran [Canada] ; Mary M. Hilt [Canada] ; Frank L. Graham [Canada] ; Ludvik Prevec [Canada] ; James B. Mahony [Canada] ; Chetna Sharon [Canada] ; Thierry C. Auperin [Canada] ; James M. Rini [Canada] ; Aubrey J. Tingle [Canada] ; David W. Scheifele [Canada] ; Danuta M. Skowronski [Canada] ; David M. Patrick [Canada] ; Thomas G. Voss [États-Unis] ; Lorne A. Babiuk [Canada] ; Jack Gauldie [Canada] ; Rachel L. Roper [États-Unis] ; Robert C. Brunham [Canada] ; B. Brett Finlay [Canada]Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus
004682 (2005) Zhiwei Chen ; Linqi Zhang ; Chuan Qin ; Lei Ba ; Christopher E. Yi ; Fengwen Zhang ; Qiang Wei ; Tian He ; Wenjie Yu ; Jian Yu ; Hong Gao ; Xinming Tu ; Agegnehu Gettie ; Michael Farzan ; Kwok-Yung Yuen ; David D. HoRecombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding Region
004743 (2005) Himani Bisht [États-Unis] ; Anjeanette Roberts ; Leatrice Vogel ; Kanta Subbarao ; Bernard MossNeutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein.
004767 (2005) Nigel J. Temperton [Royaume-Uni] ; Paul K. Chan [République populaire de Chine] ; Graham Simmons [États-Unis] ; Maria C. Zambon [Royaume-Uni] ; Richard S. Tedder [Royaume-Uni] ; Yasuhiro Takeuchi [Royaume-Uni] ; Robin A. Weiss [Royaume-Uni]Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
004802 (2005) Shixia Wang [États-Unis] ; Te-Hui W. Chou ; Pavlo V. Sakhatskyy ; Song Huang ; John M. Lawrence ; Hong Cao ; Xiaoyun Huang ; Shan LuIdentification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.
004807 (2005) Yuxian He [États-Unis] ; Qingyu Zhu [République populaire de Chine] ; Shuwen Liu [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Baoan Yang [République populaire de Chine] ; Jiaming Li [République populaire de Chine] ; Shibo Jiang [États-Unis]Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines
004844 (2005) Te-Hui W. Chou [États-Unis] ; Shixia Wang [États-Unis] ; Pavlo V. Sakhatskyy [États-Unis] ; Innocent Mboudoudjeck [États-Unis] ; John M. Lawrence [États-Unis] ; Song Huang [États-Unis] ; Scott Coley [États-Unis] ; Baoan Yang [République populaire de Chine] ; Jiaming Li [République populaire de Chine] ; Qingyu Zhu [République populaire de Chine] ; Shan Lu [États-Unis]Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
004D63 (2005) Christopher E. Yi [États-Unis] ; LEI BA [États-Unis] ; LINQI ZHANG [États-Unis] ; David D. Ho [États-Unis] ; ZHIWEI CHEN [États-Unis]Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain
004D72 (2005) Patrick C. Y. Woo [Hong Kong] ; Susanna K. P. Lau [Hong Kong] ; Hoi-Wah Tsoi [Hong Kong] ; Zhi-Wei Chen [États-Unis] ; Beatrice H. L. Wong [Hong Kong] ; LINQI ZHANG [États-Unis] ; Jim K. H. Chan [Hong Kong] ; Lei-Po Wong [Hong Kong] ; WEI HE [République populaire de Chine] ; CHI MA [République populaire de Chine] ; Kwok-Hung Chan [Hong Kong] ; David D. Ho [États-Unis] ; Kwok-Yung Yuen [Hong Kong]SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
004E80 (2005) Choong-Tat Keng [Singapour] ; AIHUA ZHANG [République populaire de Chine] ; SHUO SHEN [Singapour] ; Kuo-Ming Lip [Singapour] ; Burtram C. Fielding [Singapour] ; Timothy H. P. Tan [Singapour] ; Chih-Fong Chou [Singapour] ; CHAY BOON LOH [Singapour] ; SIFANG WANG [Singapour] ; JIANLIN FU [Singapour] ; XIAOMING YANG [République populaire de Chine] ; SENG GEE LIM [Singapour] ; WANJIN HONG [Singapour] ; Yee-Joo Tan [Singapour]Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies : Implications for the development of vaccines and antiviral agents
004E84 (2005) Milosz Faber [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Anjeanette Roberts [États-Unis] ; Amy B. Rice [États-Unis] ; Hilary Koprowski [États-Unis] ; Bernhard Dietzschold [États-Unis] ; Matthias J. Schnell [États-Unis]A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARs-CoV-neutralizing antibodies
005409 (2004) Ursula J. Buchholz [États-Unis] ; Alexander Bukreyev ; Lijuan Yang ; Elaine W. Lamirande ; Brian R. Murphy ; Kanta Subbarao ; Peter L. CollinsContributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.
005473 (2004) Elisabetta Traggiai [Suisse] ; Stephan Becker ; Kanta Subbarao ; Larissa Kolesnikova ; Yasushi Uematsu ; Maria Rita Gismondo ; Brian R. Murphy ; Rino Rappuoli ; Antonio LanzavecchiaAn efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.
005475 (2004) Tong Zhou ; Hong Wang ; Danlin Luo ; Thomas Rowe ; Zheng Wang ; Robert J. Hogan ; Shihong Qiu ; Robert J. Bunzel ; Guoqiang Huang ; Vinod Mishra ; Thomas G. Voss ; Robert Kimberly ; Ming LuoAn Exposed Domain in the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Induces Neutralizing Antibodies
006471 (2000) L. Kuo [États-Unis] ; G J Godeke ; M J Raamsman ; P S Masters ; P J RottierRetargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.
006534 (1996) C. Smerdou [Espagne] ; I M Anton ; J. Plana ; R. Curtiss ; L. EnjuanesA continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity.
001812 (2013) Rui-Ping Wu [République populaire de Chine] ; Jia-Zi Meng ; Yu-Xian He[Construction and screening of SARS-CoV S protein-specific phage displayed antigen library].
001832 (2013) Huihui Mou [Pays-Bas] ; V Stalin Raj ; Frank J M. Van Kuppeveld ; Peter J M. Rottier ; Bart L. Haagmans ; Berend Jan BoschThe receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies.
001895 (2013) Qianqian Yao [République populaire de Chine] ; Paul S. Masters ; Rong YeNegatively charged residues in the endodomain are critical for specific assembly of spike protein into murine coronavirus.
001A05 (2013) Qiong Zhao [République populaire de Chine] ; Jiayi Zhu ; Weijuan Zhu ; Xunliang Li ; Ye Tao ; Xiaonan Lv ; Xue Wang ; Jiechao Yin ; Cheng He ; Xiaofeng RenA monoclonal antibody against transmissible gastroenteritis virus generated via immunization of a DNA plasmid bearing TGEV S1 gene.
001C48 (2012) Byoung-Shik Shim [Corée du Sud] ; Konrad Stadler ; Huan Huu Nguyen ; Cheol-Heui Yun ; Dong Wook Kim ; Jun Chang ; Cecil Czerkinsky ; Man Ki SongSublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain.
001C71 (2012) Jun Huang [République populaire de Chine] ; Yingnan Cao [République populaire de Chine] ; Xianzhang Bu [République populaire de Chine] ; Changyou Wu [République populaire de Chine]Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction
001C82 (2012) Xiaorong Zhang [République populaire de Chine] ; Yantao Wu ; Yezhen Huang ; Xiufan LiuProtection conferred by a recombinant Marek's disease virus that expresses the spike protein from infectious bronchitis virus in specific pathogen-free chicken.
001D09 (2012) Siqingaowa Suo [République populaire de Chine] ; Yudong Ren ; Guangxing Li ; Dante Zarlenga ; Ri-E Bu ; Dingding Su ; Xunliang Li ; Pengchong Li ; Fandan Meng ; Chao Wang ; Xiaofeng RenImmune responses induced by DNA vaccines bearing Spike gene of PEDV combined with porcine IL-18.
001D15 (2012) Di-Qiu Liu [République populaire de Chine] ; Jun-Wei Ge ; Xin-Yuan Qiao ; Yan-Ping Jiang ; Song-Mei Liu ; Yi-Jing LiHigh-level mucosal and systemic immune responses induced by oral administration with Lactobacillus-expressed porcine epidemic diarrhea virus (PEDV) S1 region combined with Lactobacillus-expressed N protein.
001D22 (2012) Yutaka Terada [Japon] ; Yuto Shiozaki [Japon] ; Hiroshi Shimoda [Japon] ; Hassan Youssef Abdel Hamid Mahmoud [Japon] ; Keita Noguchi [Japon] ; Yumiko Nagao [Japon] ; Masayuki Shimojima [Japon] ; Hiroyuki Iwata [Japon] ; Takuya Mizuno [Japon] ; Masaru Okuda [Japon] ; Masahiro Morimoto [Japon] ; Toshiharu Hayashi [Japon] ; Yoshikazu Tanaka [Japon] ; Masami Mochizuki [Japon] ; Ken Maeda [Japon]Feline infectious peritonitis virus with a large deletion in the 5'-terminal region of the spike gene retains its virulence for cats.
002062 (2011) Lanying Du [États-Unis] ; Xiujuan Zhang ; Jixiang Liu ; Shibo JiangProtocol for recombinant RBD-based SARS vaccines: protein preparation, animal vaccination and neutralization detection.
002077 (2011) Kazuya Shirato [Japon] ; Madoka Maejima ; Shutoku Matsuyama ; Makoto Ujike ; Ayako Miyazaki ; Natsumi Takeyama ; Hidetoshi Ikeda ; Fumihiro TaguchiMutation in the cytoplasmic retrieval signal of porcine epidemic diarrhea virus spike (S) protein is responsible for enhanced fusion activity.
002114 (2011) Tohru Miyoshi-Akiyama [Japon] ; Isao Ishida ; Masaya Fukushi ; Keina Yamaguchi ; Yusuke Matsuoka ; Takashi Ishihara ; Masayoshi Tsukahara ; Seisuke Hatakeyama ; Norikazu Itoh ; Aki Morisawa ; Yoshiyuki Yoshinaka ; Naoki Yamamoto ; Zhang Lianfeng ; Qin Chuan ; Teruo Kirikae ; Takehiko SasazukiFully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model.
002117 (2011) Ilona Glowacka [Allemagne] ; Stephanie Bertram ; Marcel A. Müller ; Paul Allen ; Elizabeth Soilleux ; Susanne Pfefferle ; Imke Steffen ; Theodros Solomon Tsegaye ; Yuxian He ; Kerstin Gnirss ; Daniela Niemeyer ; Heike Schneider ; Christian Drosten ; Stefan PöhlmannEvidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.
002147 (2011) Han-Xin Lin [Canada] ; Yan Feng ; Xinming Tu ; Xuesen Zhao ; Chih-Heng Hsieh ; Lauren Griffin ; Murray Junop ; Chengsheng ZhangCharacterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry.
002150 (2011) Juan Reguera [Espagne] ; Desiderio Ordo O [Espagne] ; César Santiago [Espagne] ; Luis Enjuanes [Espagne] ; José M. Casasnovas [Espagne]Antigenic modules in the N-terminal S1 region of the transmissible gastroenteritis virus spike protein.
002227 (2011) Jung-Eun Park [Corée du Sud] ; Deu John M. Cruz [Corée du Sud] ; Hyun-Jin Shin [Corée du Sud]Receptor-bound porcine epidemic diarrhea virus spike protein cleaved by trypsin induces membrane fusion
002277 (2011) Yi-Ning Chen [États-Unis] ; Ching Ching Wu [États-Unis] ; Tsang Long Lin [États-Unis]Identification and characterization of a neutralizing-epitope-containing spike protein fragment in turkey coronavirus
002405 (2010) Wei-Min Zhou [République populaire de Chine] ; Wen-Ling Wang ; Wen-Jie Tan ; Ling-Lin Zhang ; Xiao Yin ; Rou-Jian Lu ; Hui-Juan Wang[Development of serological detection assays for human coronavirus HKU1 infection and its application].
002479 (2010) Chao Wang [République populaire de Chine] ; Xiaofeng RenPreparation and characterization of polyclonal antibody against severe acute respiratory syndrome-associated coronavirus spike protein.
002493 (2010) Jody D. Berry [États-Unis, Canada] ; Kevin Hay [États-Unis] ; James M. Rini [États-Unis] ; Meng Yu ; Linfa Wang ; Francis A. Plummer [États-Unis, Canada] ; Cindi R. Corbett [États-Unis, Canada] ; Anton Andonov [États-Unis, Canada]Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology
002547 (2010) Sandrine Belouzard [États-Unis] ; Ikenna Madu ; Gary R. WhittakerElastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain.
002589 (2010) Yanchen Zhou [États-Unis] ; Kai Lu ; Susanne Pfefferle ; Stephanie Bertram ; Ilona Glowacka ; Christian Drosten ; Stefan Pöhlmann ; Graham SimmonsA single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.
002981 (2009) Shutoku Matsuyama [Japon] ; Fumihiro TaguchiTwo-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis.
002A09 (2009) John E. Pak [Canada] ; Chetna Sharon ; Malathy Satkunarajah ; Thierry C. Auperin ; Cheryl M. Cameron ; David J. Kelvin ; Jayaraman Seetharaman ; Alan Cochrane ; Francis A. Plummer ; Jody D. Berry ; James M. RiniStructural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain.
002A26 (2009) Hong-Long Ji [États-Unis] ; Weifeng Song ; Zhiqian Gao ; Xue-Feng Su ; Hong-Guang Nie ; Yi Jiang ; Ji-Bin Peng ; Yu-Xian He ; Ying Liao ; Yong-Jian Zhou ; Albert Tousson ; Sadis MatalonSARS-CoV proteins decrease levels and activity of human ENaC via activation of distinct PKC isoforms.
002A68 (2009) Jeroen Corver [Pays-Bas] ; Rene Broer ; Puck Van Kasteren ; Willy SpaanMutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entry.
002B01 (2009) Ying Guo [États-Unis] ; Jennifer Tisoncik ; Susanna Mcreynolds ; Michael Farzan ; Bellur S. Prabhakar ; Thomas Gallagher ; Lijun Rong ; Michael CaffreyIdentification of a new region of SARS-CoV S protein critical for viral entry.
002C15 (2009) Junbao Yang [États-Unis] ; Eddie James [États-Unis] ; Michelle Roti [États-Unis] ; Laurie Huston [États-Unis] ; John A. Gebe [États-Unis] ; William W. Kwok [États-Unis]Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals
002E43 (2009) W. P. Poh [Singapour] ; T. Narasaraju [Singapour] ; N. A. Pereira [Singapour] ; F. Zhong [Singapour] ; M. C. Phoon [Singapour] ; P. A. Macary [Singapour] ; S. H. Wong [Singapour] ; J. Lu [Singapour] ; D. R. Koh [Singapour] ; Vincent T. K. Chow [Singapour]Characterization of cytotoxic T‐lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD‐integrin‐binding motif
002F91 (2008) Feng Mu [République populaire de Chine] ; Dongsheng Niu [République populaire de Chine] ; Jingsong Mu [République populaire de Chine] ; Bo He [République populaire de Chine] ; Weiguo Han [République populaire de Chine] ; Baoxing Fan [République populaire de Chine] ; Shengyong Huang [République populaire de Chine] ; Yan Qiu [République populaire de Chine] ; Bo You [République populaire de Chine] ; Weijun Chen [République populaire de Chine]The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus
003009 (2008) Sarmistha Basak [Canada] ; Xiaolei Hao ; Andrew Chen ; Michel Chrétien ; Ajoy BasakStructural and biochemical investigation of heptad repeat derived peptides of human SARS corona virus (hSARS-CoV) spike protein.
003010 (2008) Fang Li [États-Unis]Structural Analysis of Major Species Barriers between Humans and Palm Civets for Severe Acute Respiratory Syndrome Coronavirus Infections▿
003036 (2008) Hongliang Wang [République populaire de Chine] ; Peng Yang [République populaire de Chine] ; Kangtai Liu [République populaire de Chine] ; Feng Guo [République populaire de Chine] ; Yanli Zhang [République populaire de Chine] ; Gongyi Zhang [États-Unis] ; Chengyu Jiang [République populaire de Chine]SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021